Joyce M. Lee, M.D., M.P.H.
Associate Professor, Department of Pediatrics and Communicable Diseases
I am a pediatrician, diabetes specialist, and clinical and health services researcher. I am very interested in the notion that human centered design and design thinking combined with emerging technologies such as mobile technology, social media, and data visualization can transform the research enterprise and the delivery of clinical care.
In terms of my professional history, I was recently promoted to Associate Professor of Pediatrics at the University of Michigan Medical School and Associate Professor in the Department of Environmental Sciences at the University of Michigan School of Public Health. I attended Brown University for my undergraduate education, the University of Pennsylvania for my medical degree, where I was elected to the Alpha Omega Alpha Honors Society, and I completed my internship and residency in General Pediatrics at the Boston Combined Residency Program (Children's Hospital, Boston, and Boston Medical Center).
I am one of few individuals across the country who has completed dual training in Pediatric Endocrinology and Pediatric Health Services Research. In addition, I received my Masters in Public Health from the Department of Health Management and Policy at the University of Michigan.
To date, my research has agenda focused on the epidemiology and health outcomes of childhood diabetes (type 1 and type 2) and obesity. I am the principal investigator on several NIH-funded studies focusing on childhood obesity, linear growth, and type 2 diabetes risk. In 2009 I was named a Brehm Investigator by the Brehm Center for Type 1 Diabetes Research. In addition, I am site Principal Investigator for the University of Michigan for national diabetes registries including the Type 1 Diabetes Exchange and the Pediatric Diabetes Consortium.
I am very interested in the use of emerging technologies for accelerating clinical care and research. I co-direct the Program in Mobile Technology for Enhancing Child Health, which has the goal of creating mobile technology systems that can enhance chronic disease adherence in children, with a specific focus on adolescents with type 1 diabetes. In addition, in June 2013, I was appointed as the first Social Media Editor for JAMA Pediatrics.
M.P.H., Health Management and Policy, University of Michigan, 2006
M.D., University of Pennsylvania, 2000
B.A., Brown University,1995
Pediatric Endocrinology, Pediatric Health Services Research, C.S. Mott Children’s Hospital, University of Michigan, 2003-2006
Pediatrics, Children's Hospital Boston & Boston Medical Center, Harvard Medical School 2000-2003
Longitudinal Associations between Poverty and Obesity from the Birth through Adolescence.
Am J Public. In press.
Predictors of urinary bisphenol A and phthalate metabolite concentrations in Mexican children.
Chemosphere. doi: 10.1016/j.chemosphere.2013.08.038 [Epub ahead of print].
Screening Practices for Identifying Type 2 Diabetes in Adolescents.
J Adolesc Health. 2013 Aug 19. pii: S1054-139X(13)00368-6. doi: 10.1016/j.jadohealth.2013.07.003. [Epub ahead of print].
Race and Socioeconomic Status are Associated with Insulin Pump Therapy in Youth in the First Year Following Diagnosis of Type 1 Diabetes.
Diabetes Technol Ther. 2013 Jul 19. [Epub ahead of print].
Bisphenol A and Chronic Disease Risk Factors in US Children.
Pediatrics. 2013 Sep;132(3):e637-45. doi: 10.1542/peds.2013-0106. Epub 2013 Aug 19.
Effects of hypothetical type 2 diabetes genetic testing on parents' efforts to prevent diabetes in children.
Clin Pediatr (Phila). Sep 2013;52(9):821-828.
The promise and peril of mobile health applications for diabetes and endocrinology.
Pediatrics Diabetes 2013 Jun;14(4):231-8. doi: 10.1111/pedi.12034. Epub 2013 Apr. 30.
A risk score for identifying overweight adolescents with dysglycemia in primary care settings.
J Pediatr Endocrinol Metab. 2013;26(5-6):477-88. doi: 10.1515/jpem-2012-0259.
State-to-state variability in Title V coverage for children with diabetes.
J Pediatr. 2013 Jan 13. pii: S0022-3476(12)01455-2. doi: 10.1016/j.jpeds.2012.12.009. Epub 2013 Jan 13.
Multiple levels of social disadvantage and links to obesity in adolescence and young adulthood.
J Sch Health. 2013 Mar;83(3):139-49. doi:10.1111/josh.12009.
Cost-effectiveness of screening strategies for identifying pediatric diabetes and dysglycemia.
JAMA Pediatr. 2013 Jan 1;167(1):32-9. doi:10.1001/jamapediatrics.2013.419.
The right to move: a multidisciplinary lifespan conceptual framework.
Curr Gerontol Geriatr Res 2012, Article ID 873937, doi:10.1155/2012/873937.
Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children.
J Pediatr 2012 Oct 20. pii: S0022-3476(12)01066-9. doi: 10.1016/j.jpeds.2012.09.017. [Epub ahead of print]
Tackling childhood overweight and obesity: Thresholds and beyond.
Arch Pediatr Adolesc Med 2012 Nov 5:1-2. doi: 10.1001/jamapediatrics.2013.426. [Epub ahead of print]
Excess body mass index years, a measure of degree and duration of excess weight, and risk for incident diabetes.
Arch Pediatr Adolesc Med. 2012 Jan;166(1):42-8.
Evaluation of nonfasting tests to screen for childhood and adolescent dysglycemia
Diabetes Care. 2011 Dec;34(12):2597-602. Epub 2011 Sep 27.
Obesity reduction within a generation: the dual roles of prevention and treatment.
Obesity (Silver Spring). 2011 Oct;19(10):2107-10. doi: 10.1038/oby.2011.199. Epub 2011 Jun 30.
Associations between glucose tolerance and sex hormone binding globulin among women with recent gestational diabetes mellitus.
Diabetes Res Clin Pract. 2011 Sep;93(3):e110-2. Epub 2011 Jun 28.
Is waist circumference a better predictor of insulin resistance than body mass index in U.S. adolescents?
J Adolesc Health. 2011 Sep;49(3):330-3. Epub 2011 May 4.
Health Utilities for Children and Adults with Type 1 Diabetes.
Med Care. 2011 Oct;49(10):924-931.
Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents?
J Pediatr 2011 Jun;158(6):947-952.e1-3. Epub 2010 Dec 30.
Longitudinal influences of friends and parents upon unprotected vaginal intercourse in adolescents.
Contraception 2011 Feb; 83(2):138-44. Epub 2010 Aug 23.
Age and Sex Differences in Hospitalizations Associated with Diabetes.
J Womens Health (Larchmt). 2010 Nov;19(11):2033-42. Epub 2010 Oct 12.
Validation of Measures of Satisfaction With and Impact of Continuous and Conventional Glucose Monitoring.
Diabetes Technol Ther 2010 Sept; 12(9):679-684. [Listed as study author]
The Pediatric Diabetes Consortium: Improving care of children with type 1 diabetes through collaborative research.
Diabetes Technol Ther. 2010 Sept; 12(9):685-8. [Listed as study author]
Neck circumference as a screening measure for identifying children with high body mass index.
Pediatrics. 2010 Aug;126(2):e306-10. Epub 2010 July 5.
Variation of Interstitial Glucose Measurements Assessed by Continuous Glucose Monitors in Healthy, Non-diabetic Individuals.
Diabetes Technol Ther. 2010 June;33(6):1297-9. Epub 2010 Mar 9.
Prolonged Nocturnal Hypoglycemia is Common During 12 Months of Continuous Glucose Monitoring in Children and Adults with Type 1 Diabetes.
Diabetes Care. 2010 May;33(5):1004-8. Epub 2010 Mar 3.
The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes.
Diabetes Care. 2010 Jun;33(6):1269-1274. Epub 2010 Mar 23.
Don’t Children Grow Out of their Obesity? Weight Transitions in Early Childhood.
Clin Pediatr (Phila) 2010 May;49(5):466-9. Epub 2010 Jan 28.
Does childhood overweight, parental perception of overweight, or family history of diabetes mellitus increase parental perception of type 2 diabetes risk for their child?
J Pediatr Endocrinol Metab 2010 Mar;23(3):267-70.
Body Mass Index and Timing of Pubertal Initiation in Boys.
Arch Pediatr Adolesc Med 2010;164(2):139-144.
Getting Heavier, Younger: Birth Cohort Effects on Obesity over the Life Course.
Int J Obes (Lond) 2009 Dec 1. 2010 Apr;34(4):614-23. Epub 2009 Dec 1.
The Effect of Continuous Glucose Monitoring in Well-controlled Type 1 Diabetes.
Diabetes Care 2009 Aug;32(8):1378-83. Epub 2009 May 8.
Short stature in a population-based cohort: Social, emotional, and behavioral functioning.
Pediatrics 2009; 124: 903-910. Epub 2009 Aug 17.
Poor performance of body mass index as a marker for hypercholesterolemia in children and adolescents.
Arch Pediatr Adolesc Med 2009;163(8):716-23.
Waist Circumference Percentile Thresholds for Identifying Adolescents with Insulin Resistance in Clinical Practice.
Pediatr Diabetes 2009 Aug;10(5):336-42. Epub 2008 Oct 19.
Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation.
Pediatr Diabetes 2009; 10:492-6. Epub 2009 Jun 3.
Sugar-sweetened beverages and obesity in African-American preschool children: a longitudinal study.
Obesity (Silver Spring) 2009;17(6):1262-8. Epub 2009 Feb 5.
Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes.
N Engl J Med 2008; 359:1464-76. Epub 2008 Sep 8.
Why young adults hold the key to assessing the obesity epidemic in children.
Arch Pediatr Adolesc Med 2008; 162(7):682-687.
Geographic distribution of childhood diabetes and obesity relative to the supply of pediatric endocrinologists in the United States.
J Pediatr 2008; 152(3):331-6. Epub 2007 Nov 5.
Trends in hospitalizations for diabetes among children and young adults: United States, 1993-2004.
Diabetes Care 2007; 30:3035-3039.
Weight status in young girls and the onset of puberty.
Pediatrics 2007; 119:624-630.
Thresholds of evaluations for short stature in a pediatric endocrine clinic: differences between boys versus girls?
J Pediatr Endocrinol Metab 2007; 20(1):21-26.
Vitamin D deficiency in a healthy group of mothers and newborn infants.
Clin Pediatr (Phila) 2007; 46(1):42–44.
Prevalence and determinants of insulin resistance among U.S. adolescents: a population based study.
Diabetes Care 2006; 29:2427–2432.
Tall girls: The social shaping of a medical therapy.
Arch Pediatr Adolesc Med 2006; 160:1035-1039.
Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia.
Cancer 2006; 107(6):1303-1312.
Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature.
Arch Pediatr Adolesc Med 2006; 160:263-269.
An epidemiologic profile of children with diabetes in the United States.
Diabetes Care 2006; 29(2):420-421.
Issues and practices surrounding growth hormone for short children without a hormone deficiency.
Contemp Pediatr 2005; 22(10):46-53.
An inappropriate diet.
Clin Pediatr (Phila) 2005; 44:735-7.
Molecular defects in the Growth Hormone-IGF Axis; Recent advances.
Indian J Pediatr 2005; 72(2):145-148.
Fibroblastic rheumatism: Case report and review of the literature.
Pediatr Dermatol 2002; 19(6):532-5.
Biphasic anaphylactic reactions in pediatrics.
Pediatrics 2000; 106(4):762.
Penn Med Language Link.
Acad Med 1999; 74(5).